Larynx Cancer Clinical Trial
Official title:
A Randomized Study of Vocal-cord Only vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
This is a multicentrer, randomized Bayesian Phase II trial for patients with early stage (T1N0) glottic squamous cell carcinoma treated with radical radiotherapy. The primary objective is to assess the non-inferiority of local control achieved with vocal-cord only radiotherapy (VC-RT) compared to complete larynx radiotherapy (CL-RT) in T1N0 glottic laryngeal squamous cell cancer, measured at 2-years after treatment. Secondary outcomes include overall survival, as well as voice impairment, dysphagia and quality of life, measured respectively by the voice handicap index -10 (VHI-10), the MD Anderson Dysphagia Inventory (MDADI) and the MD Anderson Symptom Inventory- Head and Neck module (MDASI-HN). Patients will be randomized in a 1:3 ratio to CL-RT (39 patients) and VC-RT (116 patients) arms. There will be stratification by tumor stage (T1a/T1b) and by institution. An interim analysis is planned after the first 55 patients enrolled on the experimental arm have a 6-month follow-up.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
| Completed |
NCT03292341 -
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.
|
N/A | |
| Completed |
NCT03653039 -
Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy
|
N/A | |
| Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
| Recruiting |
NCT05793151 -
Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy
|
N/A | |
| Completed |
NCT01700647 -
Breath Testing in Early and Late Larynx Cancer
|
N/A | |
| Completed |
NCT00169247 -
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
|
Phase 2 | |
| Completed |
NCT00600223 -
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches
|
N/A | |
| Active, not recruiting |
NCT02586207 -
Pembrolizumab in Combination With CRT for LA-SCCHN
|
Phase 1 | |
| Recruiting |
NCT04057209 -
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
|
N/A | |
| Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
| Recruiting |
NCT06086119 -
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
|
||
| Suspended |
NCT04368702 -
CONFIRM: Magnetic Resonance Guided Radiation Therapy
|
N/A | |
| Completed |
NCT05217147 -
An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma
|
||
| Active, not recruiting |
NCT03082534 -
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 2 | |
| Completed |
NCT00158652 -
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
|
Phase 3 | |
| Terminated |
NCT03479463 -
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
|
||
| Completed |
NCT03096808 -
Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 2 | |
| Completed |
NCT03028766 -
WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer
|
Phase 1 | |
| Completed |
NCT00359645 -
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
|
Phase 3 |